Division of Oncology, Section of Stem Cell Biology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Department of Pediatrics, Division of Genetics and Genomic Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Nat Commun. 2021 Jul 27;12(1):4549. doi: 10.1038/s41467-021-24800-7.
Germline pathogenic variants in DNMT3A were recently described in patients with overgrowth, obesity, behavioral, and learning difficulties (DNMT3A Overgrowth Syndrome/DOS). Somatic mutations in the DNMT3A gene are also the most common cause of clonal hematopoiesis, and can initiate acute myeloid leukemia (AML). Using whole genome bisulfite sequencing, we studied DNA methylation in peripheral blood cells of 11 DOS patients and found a focal, canonical hypomethylation phenotype, which is most severe with the dominant negative DNMT3A mutation. A germline mouse model expressing the homologous Dnmt3a mutation phenocopies most aspects of the human DOS syndrome, including the methylation phenotype and an increased incidence of spontaneous hematopoietic malignancies, suggesting that all aspects of this syndrome are caused by this mutation.
DNMT3A 种系致病性变异最近在患有过度生长、肥胖、行为和学习困难的患者中被描述(DNMT3A 过度生长综合征/DOS)。DNMT3A 基因的体细胞突变也是克隆性造血的最常见原因,并可引发急性髓系白血病(AML)。使用全基因组亚硫酸氢盐测序,我们研究了 11 名 DOS 患者外周血细胞中的 DNA 甲基化,发现了一种局灶性、典型的低甲基化表型,其在显性负性 DNMT3A 突变时最为严重。表达同源 Dnmt3a 突变的种系小鼠模型模拟了人类 DOS 综合征的大多数方面,包括甲基化表型和自发性造血恶性肿瘤发生率的增加,这表明该综合征的所有方面均由该突变引起。